A Letter to the Editor Regarding 'Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-analysis Using the GRADE Framework'.
作者信息
Volkman Hannah R, Nguyen Jennifer L, Jodar Luis, McLaughlin John M
机构信息
Pfizer Inc., 66 Hudson Blvd. E, New York, NY, 10001, USA.
出版信息
Infect Dis Ther. 2024 Oct;13(10):2203-2206. doi: 10.1007/s40121-024-01019-9. Epub 2024 Aug 24.
Abstract
摘要
相似文献
1
A Letter to the Editor Regarding 'Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-analysis Using the GRADE Framework'.致编辑的一封信，关于“mRNA-1273和BNT162b2新冠疫苗在老年人中的比较效果：使用GRADE框架的系统文献综述和荟萃分析”
Infect Dis Ther. 2024 Oct;13(10):2203-2206. doi: 10.1007/s40121-024-01019-9. Epub 2024 Aug 24.
2
A Response to: A Letter to the Editor Regarding 'Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework'.对一篇致编辑的信的回应：关于“mRNA-1273和BNT162b2新冠疫苗在老年人中的比较效果：使用GRADE框架的系统文献综述和荟萃分析”
Infect Dis Ther. 2024 Oct;13(10):2195-2202. doi: 10.1007/s40121-024-01020-2. Epub 2024 Aug 24.
3
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework.mRNA-1273和BNT162b2新冠疫苗在老年人中的比较效果：使用GRADE框架的系统文献综述和荟萃分析
Infect Dis Ther. 2024 Apr;13(4):779-811. doi: 10.1007/s40121-024-00936-z. Epub 2024 Mar 18.
4
The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis.BNT162b2 mRNA 疫苗对 SARS-CoV-2 德尔塔变异株引起的 COVID-19 的有效性：系统评价和荟萃分析。
Inflammopharmacology. 2022 Feb;30(1):149-157. doi: 10.1007/s10787-021-00915-7. Epub 2022 Jan 31.
5
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.分析新加坡成年人接种 2 剂 mRNA COVID-19 或灭活 SARS-CoV-2 疫苗以及接种加强针后的 COVID-19 发病率和严重程度。
JAMA Netw Open. 2022 Aug 1;5(8):e2228900. doi: 10.1001/jamanetworkopen.2022.28900.
6
Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP.BNT162b2 与 mRNA-1273 新冠病毒疫苗加强针在英格兰的疗效比较：OpenSAFELY-TPP 的匹配队列研究。
BMJ. 2023 Mar 15;380:e072808. doi: 10.1136/bmj-2022-072808.
7
Comparative effectiveness of different primary vaccination courses on mRNA-based booster vaccines against SARs-COV-2 infections: a time-varying cohort analysis using trial emulation in the Virus Watch community cohort.不同初级疫苗接种方案对基于 mRNA 的 SARS-CoV-2 加强疫苗有效性的比较：利用病毒观察社区队列中的试验模拟进行时变队列分析。
Int J Epidemiol. 2023 Apr 19;52(2):342-354. doi: 10.1093/ije/dyad002.
8
Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273.接种BNT162b2与mRNA-1273的成年人6个月时野生型和Delta变异株抗体水平及替代中和作用的比较
Microbiol Spectr. 2022 Apr 27;10(2):e0270221. doi: 10.1128/spectrum.02702-21. Epub 2022 Mar 7.
9
Comparative Effectiveness of mRNA-based BNT162b2 Vaccine versus Adenovirus Vector-Based Ad26.COV2.S Vaccine for the Prevention of COVID-19 among Dialysis Patients.mRNA 疫苗 BNT162b2 与腺病毒载体疫苗 Ad26.COV2.S 预防透析患者 COVID-19 的效果比较。
J Am Soc Nephrol. 2022 Apr;33(4):688-697. doi: 10.1681/ASN.2021101395. Epub 2022 Feb 8.
10
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses.在北欧国家奥密克戎为主导期间，不同异源第三剂疫苗接种方案对严重 COVID-19 的效果比较：基于人群的队列分析。
BMJ. 2023 Jul 24;382:e074325. doi: 10.1136/bmj-2022-074325.
本文引用的文献
1
Real-world comparative effectiveness of a third dose of mRNA-1273 versus BNT162b2 among adults aged ≥ 65 years in the United States.美国≥65 岁成年人中 mRNA-1273 第三剂与 BNT162b2 相比的真实世界疗效比较。
Vaccine. 2024 Nov 14;42(25):126113. doi: 10.1016/j.vaccine.2024.07.014. Epub 2024 Jul 18.
2
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework.mRNA-1273和BNT162b2新冠疫苗在老年人中的比较效果：使用GRADE框架的系统文献综述和荟萃分析
Infect Dis Ther. 2024 Apr;13(4):779-811. doi: 10.1007/s40121-024-00936-z. Epub 2024 Mar 18.
3
Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults.二价（原始毒株/奥密克戎BA.4/BA.5）新冠疫苗在成人中的比较有效性
Vaccines (Basel). 2023 Nov 11;11(11):1711. doi: 10.3390/vaccines11111711.
4
Effectiveness of the Booster Dose in Protecting against COVID-19, Colombia 2022.2022年哥伦比亚加强针预防新冠病毒病的有效性
Vaccines (Basel). 2023 Sep 7;11(9):1461. doi: 10.3390/vaccines11091461.
5
Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection.四种 COVID-19 疫苗（BNT162b2 mRNA、mRNA-1273、ChAdOx1 nCov-19 和 NVX-CoV2373）对 SARS-CoV-2 B.1.1.529（奥密克戎）感染的有效性比较。
Vaccine. 2023 Aug 31;41(38):5587-5591. doi: 10.1016/j.vaccine.2023.07.050. Epub 2023 Jul 29.
6
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses.在北欧国家奥密克戎为主导期间，不同异源第三剂疫苗接种方案对严重 COVID-19 的效果比较：基于人群的队列分析。
BMJ. 2023 Jul 24;382:e074325. doi: 10.1136/bmj-2022-074325.
7
Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status - United States, April 2021-September 2022.2021 年 4 月至 2022 年 9 月期间，按 COVID-19 疫苗接种状况划分的献血者中 SARS-CoV-2 血清流行率和原发性 SARS-CoV-2 感染发生率估计值-美国。
MMWR Morb Mortal Wkly Rep. 2023 Jun 2;72(22):601-605. doi: 10.15585/mmwr.mm7222a3.
8
Protection from Omicron Infection in Residents of Nursing and Retirement Homes in Ontario, Canada.加拿大安大略省护理院和退休之家居民对奥密克戎感染的防护。
J Am Med Dir Assoc. 2023 May;24(5):753-758. doi: 10.1016/j.jamda.2023.02.105. Epub 2023 Mar 28.
9
Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.全球 2020 年 1 月至 2022 年 4 月 SARS-CoV-2 血清流行率：基于人群的标准化研究的系统评价和荟萃分析。
PLoS Med. 2022 Nov 10;19(11):e1004107. doi: 10.1371/journal.pmed.1004107. eCollection 2022 Nov.
10
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.免疫实践咨询委员会关于使用二价加强针 COVID-19 疫苗的临时建议-美国，2022 年 10 月。
MMWR Morb Mortal Wkly Rep. 2022 Nov 11;71(45):1436-1441. doi: 10.15585/mmwr.mm7145a2.
Zotero 插件